Janusz Ławiński
- Nephrology top 5%
-
- Renal cell carcinoma treatment 4
-
- Cancer, Lipids, and Metabolism 3
- MicroRNA in disease regulation 2
-
- Lipoproteins and Cardiovascular Health 2
-
- Pancreatic and Hepatic Oncology Research 2
- Vascular Tumors and Angiosarcomas 1
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
-
- Circular RNAs in diseases 2
- Co-authors
- Jacek RyszBeata FranczykAnna Gluba-BrzózkaAleksandra Ciałkowska-RyszRobert OlszewskiMagdalena Rysz-GórzyńskaZbigniew JabłonowskiHenryk Zieliński
- Journals
- International Journal of Molecular Sciences (7 papers)Antioxidants (1 paper)Toxins (1 paper)
- Partner nations
- PolandUnited States
In The Last Decade
Janusz Ławiński
14 papers receiving 486 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Nephrology 101
- Biological Psychiatry 11
- Gastroenterology 24
- Physiology 107
- Internal Medicine 15
Countries citing papers authored by Janusz Ławiński
This map shows the geographic impact of Janusz Ławiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janusz Ławiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janusz Ławiński more than expected).
Fields of papers citing papers by Janusz Ławiński
This network shows the impact of papers produced by Janusz Ławiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janusz Ławiński. The network helps show where Janusz Ławiński may publish in the future.
Co-authorship network
The 8 scholars most cited alongside Janusz Ławiński, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 11 | |
| 4 | 2023 | 60 | |
| 5 | 2023 | 18 | |
| 6 | 2022 | 22 | |
| 7 | 2022 | 15 | |
| 8 | 2021 | 23 | |
| 9 | The Impact of CKD on Uremic Toxins and Gut Microbiotabreakdown → | 2021 | 195 |
| 10 | 2021 | 16 | |
| 11 | 2021 | 49 | |
| 12 | 2021 | 21 | |
| 13 | 2020 | 39 | |
| 14 | 2020 | 18 | |
| 15 | [The analysis of perioperative complications of percutaneous nephrolithotomy in the treatment of nephrolithiasis with the use of modified Clavien-Dindo classification]. | 2018 | 2 |
About Janusz Ławiński
Janusz Ławiński is a scholar working on Cancer Research, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 494 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Cancer, Lipids, and Metabolism (3 papers), Lipoproteins and Cardiovascular Health (2 papers), MicroRNA in disease regulation (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Circular RNAs in diseases (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). The work is most often cited by research in Nephrology (101 citations), Biological Psychiatry (11 citations) and Gastroenterology (24 citations). Janusz Ławiński has collaborated with scholars based in Poland and United States. Frequent co-authors include Jacek Rysz, Beata Franczyk, Anna Gluba-Brzózka, Aleksandra Ciałkowska-Rysz, Robert Olszewski, Magdalena Rysz-Górzyńska, Zbigniew Jabłonowski and Henryk Zieliński. Their work appears in journals such as International Journal of Molecular Sciences, Antioxidants and Toxins.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.